List of JWH cannabinoids

JWH cannabinoids are a series of synthetic cannabinoids that were developed by John W. Huffman, an organic chemist at Clemson University. They are often used in scientific research and have also been sold as designer drugs. The JWH series is named after Huffman's initials.

History

The JWH series was first synthesized in the 1990s by Huffman and his team in an effort to create a new class of cannabinoid receptor agonists for use in scientific research. The compounds were initially developed to aid in the study of the endocannabinoid system, but have since been used in a variety of other research contexts.

Structure and Function

JWH cannabinoids are structurally diverse, but all share a common feature: they are able to bind to and activate the cannabinoid receptors in the brain and other tissues. This makes them useful tools for studying the function of these receptors, as well as for exploring potential therapeutic applications of cannabinoids.

List of JWH Cannabinoids

Some of the most well-known JWH cannabinoids include:

• JWH-018: One of the first and most infamous of the JWH cannabinoids, JWH-018 is a potent synthetic cannabinoid that has been associated with numerous cases of overdose and adverse reactions.

• JWH-073: A less potent analogue of JWH-018, JWH-073 is often used in scientific research due to its more manageable effects.

• JWH-133: A selective CB2 receptor agonist, JWH-133 is often used in research into potential therapeutic applications of cannabinoids.

• JWH-200: A potent cannabinoid receptor agonist, JWH-200 has been associated with a number of adverse reactions and is often used as a reference compound in research into the toxicology of synthetic cannabinoids.

Legal Status

Due to their potential for abuse and the health risks associated with their use, many JWH cannabinoids are controlled substances in many countries. In the United States, for example, several JWH cannabinoids are classified as Schedule I controlled substances under the Controlled Substances Act.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• John W. Huffman